AMRX
AMRX
NASDAQ · Pharmaceuticals

Amneal Pharmaceuticals Inc

$14.64
+0.04 (+0.27%)
As of Feb 21, 12:30 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +689.2% upside
Low Target $65.43
Average Target $115.54
High Target $156.42
Current Price $14.64
Current
$14.64
Target
$115.54
$65.43 $115.54 avg $156.42
Scenario Analysis
Bear Case
$65.43
346.9%
Low target
Base Case
$115.54
+689.2%
Avg target
Bull Case
$156.42
+968.4%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$15.42
-5.1% from high
52-Week Low
$6.69
+119.0% from low
50-Day SMA
$13.39
+9.3% vs SMA
200-Day SMA
$10.30
+42.1% vs SMA
RSI (14)
57.4
Neutral
Target vs 52W High
$115.54
+649.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
Buy 18 61% $122.82 +670.0%